Picture of Bayer AG logo

BAYN Bayer AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareAdventurousLarge CapMomentum Trap

Brief: Bayer AG - China's Center Of Drug Evaluation Accepts Marketing Authorization Application For Asundexian

April 29 (Reuters) - Bayer AG BAYGn.DE:

BAYER AG -  CHINA'S CENTER OF DRUG EVALUATION ACCEPTS MARKETING AUTHORIZATION APPLICATION FOR ASUNDEXIAN IN STROKE PREVENTION AFTER A NON-CARDIOEMBOLIC ISCHEMIC STROKE OR TRANSIENT ISCHEMIC ATTACK

Further company coverage: [BAYGn.DE]

 (Gdansk Newsroom)

 (((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600);))

Recent news on Bayer AG

See all news